BRXL5 Antibody

What is BRXL5 protein and what is its significance in plant research?

BRXL5 (Brevis radix-like 5) is a putative protein in Oryza sativa subsp. japonica (Rice) with a molecular weight of approximately 34.4 kDa. It belongs to the BRX-like family of proteins, which are involved in plant root development and growth regulation. The full sequence of BRXL5 includes characteristic domains that suggest involvement in signaling pathways related to root architecture.

The protein sequence starts with "MHVCFHGGGG GGGGRLAKSF NVISDFTKIL IGRRGGDHAL..." and contains 323 amino acids in its full-length form . Understanding BRXL5 function provides insights into molecular mechanisms regulating root development in rice and potentially other crop species, making it valuable for agricultural research focused on improving crop resilience and productivity.

What experimental applications are currently validated for BRXL5 antibodies?

Currently available commercial BRXL5 antibodies have been validated primarily for:

• Enzyme-Linked Immunosorbent Assay (ELISA)

• Western Blotting (WB) for antigen identification

These applications allow researchers to detect and quantify BRXL5 protein expression in rice samples . Unlike some other antibodies that have been validated for immunohistochemistry or immunofluorescence, BRXL5 antibodies currently have more limited validated applications. When planning experiments, researchers should carefully review the validation documentation provided by manufacturers and consider performing their own validation tests for applications beyond those explicitly stated.

How can researchers verify BRXL5 antibody specificity in their experimental system?

Verifying antibody specificity is critical for obtaining reliable research results. For BRXL5 antibodies, researchers should implement a multi-step validation approach:

• Positive control testing: Use recombinant BRXL5 protein as a positive control to confirm antibody binding

• Negative controls: Test samples from knockout or knockdown plants lacking BRXL5 expression

• Peptide competition assay: Pre-incubate the antibody with excess purified BRXL5 protein or immunizing peptide to block specific binding sites

• Western blot analysis: Confirm single band detection at the expected molecular weight (approximately 34.4 kDa)

• Cross-reactivity assessment: Test against closely related BRX-family proteins to assess potential cross-reactivity

This systematic approach helps establish confidence in antibody specificity before proceeding with experimental applications. Unlike antibodies for some better-characterized proteins, BRXL5 antibody validation may require more extensive characterization due to the putative nature of the protein.

What are the optimal storage and handling conditions for maintaining BRXL5 antibody activity?

Proper storage and handling of BRXL5 antibodies are essential for maintaining their activity and specificity. Based on manufacturer recommendations:

When handling the antibody, avoid contamination and use sterile technique. Record the date of first use and track the number of freeze-thaw cycles to ensure experimental reproducibility. Unlike some antibodies that may tolerate multiple freeze-thaw cycles, BRXL5 antibodies appear particularly sensitive to repeated freezing and thawing.

How should researchers optimize Western blot protocols for BRXL5 detection in plant samples?

Optimizing Western blot protocols for BRXL5 detection requires attention to several critical parameters:

• Sample preparation:

  • Extract proteins using a buffer containing protease inhibitors to prevent degradation

  • Consider using specialized plant protein extraction buffers containing agents to remove phenolic compounds and other plant-specific contaminants

  • Optimize protein loading (typically 20-50 μg total protein per lane)

• Gel electrophoresis and transfer:

  • Use fresh 10-12% SDS-PAGE gels for optimal resolution of the 34.4 kDa BRXL5 protein

  • Transfer to PVDF membranes (rather than nitrocellulose) at 25V overnight at 4°C for improved retention of plant proteins

• Antibody incubation:

  • Block with 5% non-fat dry milk in TBST for 1 hour at room temperature

  • Dilute BRXL5 antibody 1:1000 in blocking buffer (optimize as needed)

  • Incubate overnight at 4°C with gentle agitation

• Signal detection:

  • Use HRP-conjugated secondary antibodies with enhanced chemiluminescence detection

  • Consider using specialized plant-optimized detection reagents to minimize background

• Controls:

  • Include recombinant BRXL5 as a positive control

  • Include molecular weight markers that bracket the expected 34.4 kDa size

  • Consider loading a non-expressing tissue as a negative control

This optimized protocol should yield specific detection of BRXL5 protein while minimizing background interference common in plant samples.

What strategies can overcome common challenges in plant protein immunodetection when working with BRXL5 antibodies?

Plant tissues present unique challenges for immunodetection that can affect BRXL5 antibody performance:

• High background issues:

  • Pre-absorb antibodies with plant extract from a species lacking BRXL5

  • Increase wash stringency with higher salt concentrations (up to 500 mM NaCl)

  • Add 0.05-0.1% SDS to wash buffers for more stringent washing

• Protein extraction challenges:

  • Use specialized plant protein extraction buffers containing PVPP to remove phenolic compounds

  • Employ two-phase extraction with phenol/SDS to improve protein quality

  • Consider using commercially available plant protein extraction kits specifically designed for rice proteins

• Cross-reactivity with related proteins:

  • Perform peptide competition assays

  • Use gradient gels to better separate proteins of similar molecular weights

  • Consider immunoprecipitation before Western blotting for enhanced specificity

• Low abundance protein detection:

  • Increase sample concentration through TCA precipitation

  • Use signal enhancement systems (e.g., biotin-streptavidin amplification)

  • Consider using more sensitive detection systems like quantum dots or tyramide signal amplification

By implementing these strategies, researchers can overcome the unique challenges posed by plant tissues when working with BRXL5 antibodies.

How can researchers apply BRXL5 antibodies in studying plant root development pathways?

BRXL5 antibodies offer powerful tools for investigating root development pathways in rice and potentially other species:

• Protein expression profiling:

  • Use Western blot analysis to detect changes in BRXL5 expression during different developmental stages

  • Compare BRXL5 protein levels across various root zones (meristematic, elongation, maturation)

  • Assess BRXL5 expression in response to environmental stressors (drought, salinity, nutrient deficiency)

• Protein-protein interaction studies:

  • Employ co-immunoprecipitation with BRXL5 antibodies to identify interacting proteins

  • Perform pull-down assays to validate interaction partners identified through other methods

  • Use proximity ligation assays to confirm interactions in planta

• Chromatin immunoprecipitation (ChIP) adaptations:

  • If BRXL5 functions as a transcriptional regulator, modified ChIP protocols can identify DNA binding sites

  • Combine with high-throughput sequencing (ChIP-seq) to map genome-wide binding patterns

• Tissue-specific analyses:

  • Develop immunohistochemistry protocols to localize BRXL5 within specific root tissues

  • Compare expression patterns between primary and lateral roots

  • Evaluate changes in localization during stress responses

These approaches can reveal the mechanistic role of BRXL5 in root development pathways, potentially identifying targets for crop improvement strategies.

What methodological approaches enable quantitative analysis of BRXL5 expression across different experimental conditions?

Quantitative analysis of BRXL5 requires rigorous methodological approaches to ensure accuracy and reproducibility:

• Quantitative Western blotting:

  • Use internal loading controls (e.g., GAPDH, actin, or tubulin)

  • Implement standard curves with recombinant BRXL5 protein

  • Employ digital imaging systems with expanded dynamic range

  • Apply statistical analysis to densitometry measurements across biological replicates

• ELISA-based quantification:

  • Develop sandwich ELISA using capture and detection antibodies for BRXL5

  • Create standard curves with purified recombinant BRXL5 protein

  • Calculate concentration based on absorbance readings against standards

• Normalizing for sample variation:

  • Determine total protein concentration using Bradford or BCA assays

  • Adjust loading volumes to ensure equal protein amounts across samples

  • Consider using total protein staining methods (e.g., Ponceau S) as reference

• Statistical analysis frameworks:

  • Apply appropriate statistical tests (ANOVA, t-test) based on experimental design

  • Calculate confidence intervals for BRXL5 measurements

  • Perform power analysis to determine required sample sizes for detecting biologically significant differences

How do post-translational modifications affect BRXL5 antibody recognition, and how can researchers account for this?

Post-translational modifications (PTMs) can significantly impact antibody recognition of BRXL5 protein:

• Potential PTMs affecting BRXL5 recognition:

  • Phosphorylation at serine/threonine residues can alter epitope accessibility

  • Ubiquitination may occur at lysine residues, potentially masking antibody binding sites

  • Glycosylation patterns specific to plant proteins may interfere with antibody binding

  • Proteolytic processing could remove epitopes recognized by the antibody

• Methodological approaches to account for PTMs:

  • Use multiple antibodies targeting different epitopes of BRXL5

  • Implement phosphatase treatment before immunodetection to remove phosphorylation

  • Apply deglycosylation enzymes to remove carbohydrate modifications

  • Consider protein conformation by using both reducing and non-reducing conditions

• Advanced techniques for PTM-specific detection:

  • Employ phospho-specific antibodies if phosphorylation sites are identified

  • Use PTM-specific staining methods in conjunction with BRXL5 antibody detection

  • Apply mass spectrometry to identify and characterize PTMs on immunoprecipitated BRXL5

This comprehensive approach helps researchers account for the impact of PTMs on BRXL5 antibody recognition, providing a more complete understanding of the protein's functional state under different experimental conditions.

How can researchers validate BRXL5 antibody cross-reactivity with orthologs in other plant species?

Validating cross-reactivity with BRXL5 orthologs requires a systematic approach:

• Sequence homology analysis:

  • Perform sequence alignment between rice BRXL5 and potential orthologs

  • Focus on epitope regions targeted by the antibody

  • Calculate percent identity and similarity in these regions

• Recombinant protein testing:

  • Express recombinant BRXL5 orthologs from target species

  • Test antibody binding via Western blot and ELISA

  • Compare binding affinity/signal strength across species

• Western blot validation:

  • Run protein extracts from multiple species in parallel

  • Confirm band detection at appropriate molecular weights

  • Perform peptide competition assays for each species

• Epitope mapping:

  • Use peptide arrays to identify specific binding regions

  • Compare conservation of these regions across species

  • Predict cross-reactivity based on epitope conservation

The extent of cross-reactivity typically correlates with evolutionary relatedness, with closer relatives (e.g., other grasses) more likely to show recognition compared to more distant plant families.

What novel methodological approaches are emerging for studying protein-protein interactions involving BRXL5?

Several cutting-edge approaches show promise for studying BRXL5 protein interactions:

• Proximity-dependent labeling techniques:

  • BioID or TurboID fusion with BRXL5 to identify proximal proteins in vivo

  • APEX2 fusion for rapid, spatially-resolved protein interaction mapping

  • These approaches can reveal transient interactions missed by traditional methods

• Single-molecule techniques:

  • Förster Resonance Energy Transfer (FRET) with fluorescently-tagged BRXL5

  • Bimolecular Fluorescence Complementation (BiFC) to visualize interactions in planta

  • Total Internal Reflection Fluorescence (TIRF) microscopy for monitoring dynamic interactions

• Chemical crosslinking with mass spectrometry (XL-MS):

  • Apply protein-specific crosslinkers to stabilize interactions

  • Identify interacting proteins and interface residues through mass spectrometry

  • Map interaction networks with specialized computational tools

• Protein complementation assays:

  • Split luciferase complementation for quantitative interaction analysis

  • Split ubiquitin systems adapted for plant membrane protein interactions

  • Yeast three-hybrid systems to detect RNA-mediated protein interactions

These emerging techniques can reveal previously undetectable BRXL5 interactions, providing deeper insight into its biological functions in plant development and stress responses.

How can researchers integrate antibody-based detection with omics approaches for comprehensive understanding of BRXL5 function?

Integrating antibody-based detection with omics approaches creates powerful research synergies:

• Integration with transcriptomics:

  • Compare BRXL5 protein levels (detected by antibodies) with mRNA expression profiles

  • Identify post-transcriptional regulation by calculating protein-to-mRNA ratios

  • Correlate BRXL5 protein abundance with expression of potential target genes

• Integration with proteomics:

  • Use BRXL5 antibodies for immunoprecipitation followed by mass spectrometry (IP-MS)

  • Compare antibody-based quantification with MS-based protein abundance measurements

  • Identify post-translational modifications through MS analysis of immunoprecipitated BRXL5

• Integration with metabolomics:

  • Correlate BRXL5 protein levels with metabolite profiles in the same samples

  • Identify metabolic pathways potentially regulated by BRXL5

  • Develop predictive models linking BRXL5 abundance to metabolic outputs

• Computational integration frameworks:

  • Apply machine learning approaches to identify patterns across multi-omics datasets

  • Develop network models incorporating BRXL5 protein abundance data

  • Use Bayesian approaches to infer causal relationships between BRXL5 and other molecular components

This integrated approach provides a systems-level understanding of BRXL5 function, revealing its role within complex biological networks rather than in isolation.

What controls and validation steps are essential when developing new applications for BRXL5 antibodies?

Developing new applications for BRXL5 antibodies requires rigorous controls and validation:

• Essential experimental controls:

  • Positive control: Recombinant BRXL5 protein or overexpression system

  • Negative control: BRXL5 knockout/knockdown samples

  • Isotype control: Non-specific IgG from the same species as BRXL5 antibody

  • Pre-immune serum control: Serum collected before immunization (for polyclonal antibodies)

  • Peptide competition control: Pre-incubation with immunizing peptide

• Method-specific validation steps:

  • For immunohistochemistry: Confirm specific cellular/tissue staining patterns

  • For immunoprecipitation: Verify pull-down efficiency with Western blot

  • For ChIP applications: Validate enrichment of known target sequences

  • For new ELISAs: Establish detection limits, dynamic range, and reproducibility

• Cross-validation approaches:

  • Validate findings with multiple antibodies targeting different BRXL5 epitopes

  • Confirm results using complementary techniques (e.g., mass spectrometry)

  • Compare antibody-based results with genetic approaches (overexpression, knockout)

  • Perform biological replicates across different experimental conditions

• Documentation requirements:

  • Record detailed antibody information (catalog number, lot, dilution)

  • Document all validation experiments and results

  • Maintain validation data for each new application developed

  • Include comprehensive validation information in publications

These rigorous controls and validation steps ensure that new applications developed with BRXL5 antibodies produce reliable and reproducible results, advancing our understanding of this important plant protein.

What are the most common sources of false positives and false negatives when using BRXL5 antibodies, and how can they be mitigated?

Understanding and mitigating sources of false results is critical for reliable BRXL5 detection:

By systematically addressing these potential issues, researchers can significantly improve the reliability of their BRXL5 detection assays.

How can researchers distinguish between specific and non-specific binding in challenging experimental contexts?

Distinguishing specific from non-specific binding requires multiple complementary approaches:

• Competitive binding assays:

  • Pre-incubate antibody with excess purified antigen or immunizing peptide

  • Compare signal with and without competition

  • Specific binding should be significantly reduced after competition

• Gradient antibody concentration analysis:

  • Test serial dilutions of primary antibody

  • Plot signal-to-noise ratio across concentrations

  • Specific binding shows dose-dependent pattern differing from non-specific binding

• Multiple antibody validation:

  • Test different antibodies targeting different BRXL5 epitopes

  • Compare binding patterns across antibodies

  • Consistent detection across antibodies suggests specific binding

• Genetic controls:

  • Compare wild-type with BRXL5 knockdown/knockout samples

  • Quantify signal reduction in knockout samples

  • Remaining signal in knockout samples indicates non-specific binding

• Signal specificity verification:

  • Perform immunoprecipitation followed by mass spectrometry

  • Identify proteins pulled down by the antibody

  • Confirm presence of BRXL5 in the precipitated material

These complementary approaches provide strong evidence for distinguishing specific BRXL5 detection from non-specific artifacts, particularly important in challenging plant tissue contexts.

What emerging technologies might enhance the specificity and sensitivity of BRXL5 detection in the future?

Several emerging technologies show promise for advancing BRXL5 detection:

• Next-generation antibody technologies:

  • Single-domain antibodies (nanobodies) for improved tissue penetration

  • Synthetic recombinant antibodies with enhanced specificity

  • Aptamer-based detection methods as alternatives to traditional antibodies

• Advanced imaging approaches:

  • Super-resolution microscopy for subcellular BRXL5 localization

  • Expansion microscopy to physically enlarge samples for improved resolution

  • Light-sheet microscopy for rapid 3D imaging of BRXL5 distribution

• Digital detection platforms:

  • Single-molecule array (Simoa) technology for ultra-sensitive protein detection

  • Digital ELISA formats with dramatically improved sensitivity

  • Microfluidic antibody-based detection systems for reduced sample requirements

• AI-enhanced data analysis:

  • Machine learning algorithms for automated signal pattern recognition

  • Deep learning approaches for distinguishing specific from non-specific binding

  • Predictive modeling of antibody-epitope interactions to improve reagent design

These emerging technologies promise to overcome current limitations in BRXL5 detection, enabling more precise studies of this important plant protein, particularly in contexts where protein abundance is low or sample availability is limited.

How might protein language models and computational approaches improve our understanding of BRXL5 antibody interactions?

Protein language models and computational approaches offer powerful new tools for BRXL5 research:

• Antibody-epitope prediction:

  • Protein language models (PLMs) like ESM2 and ProtT5 can predict antibody binding sites

  • These predictions can guide epitope selection for new antibody development

  • Transfer learning approaches can fine-tune models for plant-specific proteins

• Cross-reactivity prediction:

  • Computational models can assess potential cross-reactivity with related proteins

  • Embedding-based approaches can identify proteins with similar structural features

  • These predictions can help researchers select more specific antibodies

• Structure-based optimization:

  • AlphaFold2-predicted structures can inform antibody design and optimization

  • Molecular dynamics simulations can model antibody-antigen interactions

  • Virtual screening can identify potential binding interference from post-translational modifications

• Ensemble modeling approaches:

  • Combining multiple computational models improves prediction accuracy

  • Ensemble methods have shown superior performance in predicting antibody properties

  • These approaches can guide experimental design and interpretation

As demonstrated in recent research on antibody polyreactivity, protein language models outperformed structure-based descriptors, achieving AUC values of 0.862-0.891 across different model architectures . Similar approaches could significantly advance our understanding of BRXL5 antibody interactions and improve reagent development.